Delivery Order SPE2DB22D1202-SPE2DB24FVJH0

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,367.37 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Otezla 30mg tablets to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025....
The Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of OTEZLA 30 mg tablets. This contract, valued at $16,129.12, has an ultimate completion date of May 8, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract worth $31,201.02 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Otezla 30 mg tablets and has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,656.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Otezla 30 mg tablets. The contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is likely part of a larger indefinite delivery contract (IDC) the company holds with DLA valued at...
The Defense Logistics Agency (DLA) has awarded a $15,831.96 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets. This contract has an ultimate completion date of October 16, 2024 and is not set aside for any particular business type. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of essential medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,724.50 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $6,650.13, is for the delivery of Otezla 30 mg tablets to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, that serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,028.75 firm fixed price delivery order contract is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of September 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $20,846.88 contract is for the supply of OTEZLA 30 MG TABLET 60S. This delivery order contract is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a $33,453.09 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through July 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of medical commodities, including...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVJH0
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $19,017.00 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Otezla 30 mg tablets in 60-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by July 31, 2024.

Generated 10/29/24, 9:04 AM